Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer
Clinical trial NCT01150513 · COMPLETED
Trial details
- NCT number
- NCT01150513
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2016-01-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.